Kari L. Anderl

499 total citations
11 papers, 392 citations indexed

About

Kari L. Anderl is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kari L. Anderl has authored 11 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Kari L. Anderl's work include Cancer Genomics and Diagnostics (5 papers), Renal cell carcinoma treatment (4 papers) and Glioma Diagnosis and Treatment (4 papers). Kari L. Anderl is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Renal cell carcinoma treatment (4 papers) and Glioma Diagnosis and Treatment (4 papers). Kari L. Anderl collaborates with scholars based in United States, Netherlands and United Kingdom. Kari L. Anderl's co-authors include Robert B. Jenkins, Thomas J. Borell, David G. Bostwick, Junqi Qian, James A. Brown, Bernd W. Scheithauer, Michael M. Lieber, John F. Herath, Anton K. Raap and Rudolf H. Boerman and has published in prestigious journals such as Gastroenterology, The Journal of Urology and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Kari L. Anderl

11 papers receiving 382 citations

Peers

Kari L. Anderl
Comparison fields: 5 of 51
  • Molecular Biology 239
  • Pulmonary and Respiratory Medicine 223
  • Genetics 118
  • Cancer Research 117
  • Oncology 78
Replace Julie Niolat with:
Julie Niolat France
Alain Aurias France
Douglas C. Miller United States
Lauren Shapiro United States
H. Neumann Germany
Estelle Daudigeos‐Dubus France
Young-Hyuck Im South Korea
A. Valent France
Ilse Vlassenbroeck Belgium
Curt J. Essenburg United States
Julie Niolat France View profile →
Citations per field, relative to Kari L. Anderl
Kari L. Anderl · 1×
Citations per year, relative to Kari L. Anderl
Kari L. Anderl · 1×

Countries citing papers authored by Kari L. Anderl

Since Specialization
Citations

This map shows the geographic impact of Kari L. Anderl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari L. Anderl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari L. Anderl more than expected).

Fields of papers citing papers by Kari L. Anderl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari L. Anderl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari L. Anderl. The network helps show where Kari L. Anderl may publish in the future.

Co-authorship network of co-authors of Kari L. Anderl

This figure shows the co-authorship network connecting the top 25 collaborators of Kari L. Anderl. A scholar is included among the top collaborators of Kari L. Anderl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari L. Anderl. Kari L. Anderl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 70
2 1
3 33
4
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
43
5 36
6 3
7
Detection of p16 gene deletions in gliomas: Fluorescence in situ hybridization (FISH) versus quantitative PCR
1
8 62
9 98
10 2
11 43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026